In principle this looks like it is a good deal as it is clearly now the avenue for Humet to enjoy the benefits of being listed on the stockmarket along with the old Pharma Nutrients.
I posted the relationship between PharmaNutrients and Humet in the Ibox a few weeks back, so that in itself is nothing new.
What is interesting for investors (once the SEC take the lid off) is the matter of financials and revenues.
I only chucked a couple of hundred at this back in February as a punt, but it looks like the combined value of Pharmanutrients and Humet (now Humet) could be quite high based on the market reach and penetration of both companies in some major consumer markets.
I am very much looking forward to seeing any financial information forthcoming.
News 
Market Data 
Discover 
